PerkinElmer
check quantity

AlphaPlate-384, Shallow Well (ProxiPlate), case of 50

Shallow-well 384-well light gray microplate for lower volume and increased sensitivity. AlphaPlates were designed specifically for optimal performance in AlphaScreen and AlphaLISA assays.

Part Number
Unit Size
List Price
Your Price
Quantity
6008350
Case of 50
489.00 USD
 
more
6008359
Case of 200
1627.00 USD
 
more
Buy Now

Please enter valid quantity

Please log in to add favorites.

NULL OR EMPTY CART

Overview

PerkinElmer's exclusive AlphaPlate is designed specifically for AlphaLISA and AlphaScreen assay applications. The AlphaPlate is a unique light gray engineered microplate for reduction in cross talk and assay optimization. Our shallow-well microplate offers closer proximity to the analyzer's detector, and is designed to miniaturize your assay and utilize cost reduction advantages.

Leveraging years of assay and instrument experience in plate detection, PerkinElmer designs better microplates for better performance that guarantees better results for all PerkinElmer applications.

Specifications

Automation Compatible Yes
Color Gray
Detection Method Luminescence, Alpha
Material Polystyrene
Product Brand Name AlphaPlate
Shipping Condition Ambient
Sterile No
Unit Size Case of 50
Wells Number 384 well plate
Resources, Events & More
  • All

Application Note

Evaluating the Specificity of PD-1 and PD-L1 Blocking Antibodies Using AlphaLISA Human and Mouse PD-1/PD-L1 Binding Kits

Mouse pharmacological models continue to play a large role in the study of human disease, and mouse tool reagents have shown high utility in immunology and cancer research for decades. It can often be quicker to learn about immunology and the regulation of immune responses using a syngeneic mouse model. However, working in mouse systems can often require the development of separate mouse reagents, if the therapeutic agent of interest does not cross-react with mouse. Find out how the AlphaLISA® human PD-1/PD-L1 and AlphaLISA mouse PD-1/PD-L1 binding assays provide a fast, powerful, homogeneous platform for obtain binding potencies from potential novel drug candidates.

PDF 1 MB